Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager

Agios Pharmaceuticals Inc

NASDAQ:AGIO

Watchlist

Dividends

Price: 29.45 USD 0.65% Market Closed

Market Cap: 1.7B USD

Have any thoughts about
Agios Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 29.45 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

AGIO Alert

Agios Pharmaceuticals Inc

29.45

+0.19 (+0.65%)

52 Week Range	24.53 61.64
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Agios Pharmaceuticals Inc

What unique competitive advantages
does Agios Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Agios Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Agios Pharmaceuticals Inc.

What unique competitive advantages
does Agios Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Agios Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Agios Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Agios Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Agios Pharmaceuticals Inc.

Provide P/S
for Agios Pharmaceuticals Inc.

Provide P/E
for Agios Pharmaceuticals Inc.

Provide P/OCF
for Agios Pharmaceuticals Inc.

Provide P/FCFE
for Agios Pharmaceuticals Inc.

Provide P/B
for Agios Pharmaceuticals Inc.

Provide EV/S
for Agios Pharmaceuticals Inc.

Provide EV/GP
for Agios Pharmaceuticals Inc.

Provide EV/EBITDA
for Agios Pharmaceuticals Inc.

Provide EV/EBIT
for Agios Pharmaceuticals Inc.

Provide EV/OCF
for Agios Pharmaceuticals Inc.

Provide EV/FCFF
for Agios Pharmaceuticals Inc.

Provide EV/IC
for Agios Pharmaceuticals Inc.

Show me price targets
for Agios Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Agios Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Agios Pharmaceuticals Inc?

What are the Net Income projections
for Agios Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Agios Pharmaceuticals Inc?

What are the EPS projections
for Agios Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Agios Pharmaceuticals Inc?

What are the EBIT projections
for Agios Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Agios Pharmaceuticals Inc?

Compare the revenue forecasts
for Agios Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Agios Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Agios Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Agios Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Agios Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Agios Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Agios Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Agios Pharmaceuticals Inc.

Provide ROE
for Agios Pharmaceuticals Inc.

Provide ROA
for Agios Pharmaceuticals Inc.

Provide ROIC
for Agios Pharmaceuticals Inc.

Provide ROCE
for Agios Pharmaceuticals Inc.

Provide Gross Margin
for Agios Pharmaceuticals Inc.

Provide Operating Margin
for Agios Pharmaceuticals Inc.

Provide Net Margin
for Agios Pharmaceuticals Inc.

Provide FCF Margin
for Agios Pharmaceuticals Inc.

Show all solvency ratios
for Agios Pharmaceuticals Inc.

Provide D/E Ratio
for Agios Pharmaceuticals Inc.

Provide D/A Ratio
for Agios Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Agios Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Agios Pharmaceuticals Inc.

Provide Quick Ratio
for Agios Pharmaceuticals Inc.

Provide Current Ratio
for Agios Pharmaceuticals Inc.

Provide Cash Ratio
for Agios Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Agios Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Agios Pharmaceuticals Inc?

What is the current Free Cash Flow
of Agios Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Agios Pharmaceuticals Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Wall Street analysts forecast AGIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGIO is 56.14 USD with a low forecast of 38.6 USD and a high forecast of 77.7 USD.

AGIO Average Forecast

Wall Street Target

56.14 USD

91% Upside

AGIO Highest Forecast

Wall Street Target

77.7 USD

164% Upside

Lowest

Price Target

38.6 USD

31% Upside

Average

Price Target

56.14 USD

91% Upside

Highest

Price Target

77.7 USD

164% Upside

Agios Pharmaceuticals Inc Competitors:
Price Targets

MDGL

Madrigal Pharmaceuticals Inc

29% Upside

AMRN

Amarin Corporation PLC

32% Upside

6955

Shandong Boan Biotechnology Co Ltd

2% Downside

ANIK

Anika Therapeutics Inc

63% Upside

MDGL

Madrigal Pharmaceuticals Inc

29% Upside

AMRN

Amarin Corporation PLC

32% Upside

6955

Shandong Boan Biotechnology Co Ltd

2% Downside

ANIK

Anika Therapeutics Inc

63% Upside

005690

Pharmicell Co Ltd

67% Upside

BBIO

BridgeBio Pharma Inc

56% Upside

ALNY

Alnylam Pharmaceuticals Inc

29% Upside

RYTM

Rhythm Pharmaceuticals Inc

27% Upside

Revenue
Forecast

Revenue Estimate
Agios Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is -8%. The projected CAGR for the next 3 years is 116%.

-8%

Past Growth

116%

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Agios Pharmaceuticals Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Agios Pharmaceuticals Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-4%

Average Miss

What are analyst estimates?

What is AGIO's stock price target?

Price Target
56.14 USD

According to Wall Street analysts, the average 1-year price target for AGIO is 56.14 USD with a low forecast of 38.6 USD and a high forecast of 77.7 USD.

What is Agios Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
116%

For the last 8 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is -8%. The projected CAGR for the next 3 years is 116%.

	Cyberark Software Ltd NASDAQ:CYBR	349.29 USD 1.18%
	Crinetics Pharmaceuticals Inc NASDAQ:CRNX	32.39 USD -2.99%
	One Stop Systems Inc NASDAQ:OSS	2.37 USD -0.42%
	Check Point Software Technologies Ltd NASDAQ:CHKP	206.55 USD -1.12%
	Agios Pharmaceuticals Inc NASDAQ:AGIO	29.45 USD 0.65%
	Twist Bioscience Corp NASDAQ:TWST	40.11 USD -0.15%

	Franklin Covey Co NYSE:FC	20.78 USD 0.19%
	Mohawk Industries Inc NYSE:MHK	106.87 USD -2.04%
	Ardmore Shipping Corp NYSE:ASC	9.58 USD 2.24%
	ASGN Inc NYSE:ASGN	51.37 USD -0.75%
	Skyworks Solutions Inc NASDAQ:SWKS	61.52 USD 0.03%
	Weatherford International PLC NASDAQ:WFRD	42.74 USD 3.14%

	Johnson & Johnson NYSE:JNJ	154.58 USD -0.23%
	Bank of America Corp NYSE:BAC	39.69 USD 0.28%
	Mastercard Inc NYSE:MA	533.48 USD -0.37%
	Salesforce Inc NYSE:CRM	267.85 USD 1.19%
	Abbvie Inc NYSE:ABBV	186.06 USD 3.15%
	Home Depot Inc NYSE:HD	357.58 USD -0.57%

	Arista Networks Inc NYSE:ANET	77.91 USD 3.48%
	Visa Inc NYSE:V	335.17 USD -0.16%
	Texas Pacific Land Corp NYSE:TPL	1 334.63 USD -0.09%
	KLA Corp NASDAQ:KLAC	694.61 USD 0.75%
	Manhattan Associates Inc NASDAQ:MANH	174.58 USD 0.21%
	Monolithic Power Systems Inc NASDAQ:MPWR	583.72 USD 0.51%

	ServiceNow Inc NYSE:NOW	945.26 USD 0.71%
	EOG Resources Inc NYSE:EOG	113.07 USD -0.34%
	Monster Beverage Corp NASDAQ:MNST	58.67 USD 0.14%
	Copart Inc NASDAQ:CPRT	60.9 USD -1.73%
	Applied Materials Inc NASDAQ:AMAT	151.55 USD 0.92%
	Airbnb Inc NASDAQ:ABNB	122.51 USD 0.66%

Agios Pharmaceuticals Inc
NASDAQ:AGIO

Wall Street
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Agios Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Agios Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Agios Pharmaceuticals Inc

See Also

What is AGIO's stock price target?

Price Target
56.14 USD

What is Agios Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
116%

Company

Help

Tools

Stocks

Agios Pharmaceuticals Inc NASDAQ:AGIO

Wall Street Price Targets

AGIO Price Targets Summary Agios Pharmaceuticals Inc

Revenue Forecast

Revenue Estimate Agios Pharmaceuticals Inc

Operating Income Forecast

Operating Income Estimate Agios Pharmaceuticals Inc

Net Income Forecast

Net Income Estimate Agios Pharmaceuticals Inc

See Also

What is AGIO's stock price target? Price Target 56.14 USD

What is Agios Pharmaceuticals Inc's Revenue forecast? Projected CAGR 116%

Company

Help

Tools

Stocks

Agios Pharmaceuticals Inc
NASDAQ:AGIO

Wall Street
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Agios Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Agios Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Agios Pharmaceuticals Inc

What is AGIO's stock price target?

Price Target
56.14 USD

What is Agios Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
116%